Compound 761
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)N(C)Cc1ccccc1
- IUPAC name:
4-[4-[benzyl(methyl)amino]piperidin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide
- InChi:
InChI=1S/C38H46N6O5S2/c1-41(2)23-20-31(28-50-34-12-8-5-9-13-34)39-36-19-18-35(26-37(36)44(46)47)51(48,49)40-38(45)30-14-16-33(17-15-30)43-24-21-32(22-25-43)42(3)27-29-10-6-4-7-11-29/h4-19,26,31-32,39H,20-25,27-28H2,1-3H3,(H,40,45)/t31-/m1/s1
- InChiKey:
ZLWZKTPMZXZMEK-WJOKGBTCSA-N
External links
42601680 |
External search
Bibliography (1)
Publication | Name |
---|---|
Haixiao Zhai, Xiong Cai, Curis, Inc.. . Bcl-2 inhibitors None. | 5 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 730.30 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 5.05 | |||
TPSA | 130.81 | |||
RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009036035 | 5 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.30 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5236 | Navitoclax | DB12340 | |
0.4680 | Sulfabenzamide | DB09355 | |
0.4495 | Venetoclax | DB11581 | |
0.4438 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.4365 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
0.4188 | Pipotiazine | DB01621 | |
0.4112 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.4110 | Saccharin | DB12418 | |
0.4100 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4078 | Nelfinavir | DB00220 | |
0.4027 | Repinotan | DB06506 | |
0.3991 | 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid | DB02449 | |
0.3988 | (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide | DB03950 | |
0.3988 | (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide | DB02479 | |
0.3916 | N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE | DB07476 |